Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him
After founding Gossamer Bio $GOSS and handing the CEO’s reins to his longtime colleague and co-founder Sheila Gujrathi, biotech entrepreneur Faheem Hasnain is stepping back in to run the company at a critical juncture.
Monday morning Gossamer reported that Hasnain has been re-appointed CEO of Gossamer, weeks after their lead drug failed 2 key mid-stage trials. Now it will be up to Hasnain to work through talks with the FDA to see if there’s a path forward for the drug into a Phase III asthma study — and a partner out there in the industry who would like to carry this forward.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 94,300+ biopharma pros reading Endpoints daily — and it's free.